>

WHO Recommends Expanded Use of Malaria Vaccines for Prevention and Elimination

Updated Guidelines and Progress Report

Key Points

The World Health Organization (WHO) has released updated guidelines recommending the programmatic use of malaria vaccines for the prevention of malaria in high-risk areas.

The revised guidelines aim to accelerate progress towards the elimination of malaria, a deadly disease that claimed over 600,000 lives in 2022.

The most advanced malaria vaccine, RTS,S/AS01 (Mosquirix), has demonstrated efficacy in reducing malaria infection and transmission.

WHO encourages the development of next-generation malaria vaccines that further enhance efficacy and reduce transmission.

The Malaria Vaccine Technology Roadmap 2030 calls for the development of vaccines that can achieve at least 90% efficacy.